Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05720026
Status:
RECRUITING
Last Update Posted:
2023-02-09
First Post:
2022-11-25
Brief Title:
Study to Evaluate the Efficacy and Safety of SYSA1901 vs Perjeta of HER2-Positive Breast Cancer
Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co Ltd
Organization:
CSPC ZhongQi Pharmaceutical Technology Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-09
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-21
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-25
First Submit QC Date:
February 8 2023
Study First Post Date:
2023-02-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-08
Last Update Post Date:
2023-02-09
Last Update Post Date Type:
ACTUAL